GenePharma B.V.

Metabolic Disease Gene Therapy Development Partnership

The client required rapid scale-up of their Metabolic Disease therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Ophthalmology Gene Therapy Development Partnership

The client required rapid scale-up of their Ophthalmology therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Ophthalmology Small Molecule Development Partnership

The client required rapid scale-up of their Ophthalmology therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Commercial-Scale Production of Biosimilar Product

The client required rapid scale-up while maintaining strict quality standards and regulatory compliance. Time-to-market was critical.

Our team implemented innovative process optimization techniques, leveraged advanced manufacturing technologies, and established robust quality control systems.

Project completed 30% faster than industry average with zero quality deviations. Client achieved regulatory approval on first submission.